A Study Evaluating IV Oncaspar® and IV Gemzar® in the Treatment of Solid Tumors and Lymphoma

NCT00363610 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

19

Enrollment

INDUSTRY

Sponsor class

Stopped No recommended Phase II dose was determined.

Conditions

Tumors
Lymphoma

Interventions

DRUG: Oncaspar & Gemzar; advanced and/or solid tumors and lymphoma

Sponsor

Enzon Pharmaceuticals, Inc.